Related Experiment Video
Updated: Dec 25, 2025

Transcutaneous Microcirculatory Imaging in Preterm Neonates
Published on: December 31, 2015
Neonatal thrombosis.
Alexander Makatsariya1, Viktoriya Bitsadze1, Jamilya Khizroeva1
1Department of Obstetrics and Gynecology, I. M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.
Neonatal thromboembolism, a serious condition in infants, often results from multiple risk factors like central lines and prematurity. Understanding the unique neonatal hemostatic system is key to managing this risk.
Area of Science:
- Neonatal Medicine
- Pediatric Hematology
- Thrombosis Research
Background:
- Neonatal thromboembolism is a rare but severe condition in infants.
- It is primarily caused by multiple prothrombotic risk factors, including central venous catheters, sepsis, and prematurity.
- The neonatal hemostatic system differs significantly from adults, with lower levels of certain procoagulant proteins and anticoagulants, increasing thrombosis risk.
Purpose of the Study:
- To review the pathophysiology and risk factors of neonatal thromboembolism.
- To highlight the unique hemostatic system of neonates and its implications for thrombosis.
- To discuss the role of inherited and acquired thrombophilia in neonatal venous thromboembolism (VTE).
Main Methods:
- Literature review of neonatal thromboembolism.
- Analysis of the neonatal hemostatic system's components and function.
- Examination of risk factors, including central venous lines, sepsis, prematurity, and thrombophilia.
Main Results:
- Neonates have a prothrombotic state due to immature coagulation and fibrinolytic systems, especially preterm infants.
- Risk factors like central venous lines, sepsis, and prematurity significantly increase VTE risk.
- Maternal and neonatal thrombophilia are implicated in neonatal thrombosis development.
Conclusions:
- Neonates, particularly preterm infants, are at a higher risk for thrombosis due to their unique hemostatic profile.
- Identifying thrombophilia in high-risk newborns may aid in thromboprophylaxis.
- Further research is needed on risk factor assessment, diagnostics, and treatment strategies for neonatal VTE.
Related Concept Videos
Venous Thrombosis I: Introduction
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism III: Nursing Management
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis IV: Nursing Management

